ABCC8 and retinoblastoma: Furthermore, Sur_Dz has only been chosen due to its dose-dependent manner catalytic reactivity towards Sur mRNA which has been proven in pancreatic carcinoma and its overexpression profile in RB tumor cells [84, 85].